| 6.97 Data as of May 23 |  +0.27 / +4.03%Today’s Change | 2.56 Today|||52-Week Range 7.53 | +45.51% Year-to-Date |
| Previous close | 6.70 |
| Today’s open | 6.61 |
| Day’s range | -- - -- |
| Volume | 220,985 |
| Average volume (3 months) | 311,082 |
| Market cap | $598.0M |
| Dividend yield | -- |
| Earnings growth (last year) | +32.62% |
| Earnings growth (this year) | +66.60% |
| Earnings growth (next 5 years) | +106.50% |
| Revenue growth (last year) | +200.57% |
| P/E ratio | NM |
| Price/Sales | 8.17 |
| Price/Book | 12.49 |
| Next reporting date | August 7, 2013 |
| EPS forecast (this quarter) | -$0.11 |
| Annual revenue (last year) | $50.2M |
| Annual profit (last year) | -$81.0M |
| Net profit margin | -161.35% |
Sector Health Technology |
Industry Biotechnology |
Chairman Cam L. Garner, MBA |
President, Chief Executive Officer & Director Theodore R. Schroeder |
Corporate headquarters San Diego, California |
.
